Showing results (291-300 of 386) with videos related to
Sort By:
Pageof 39
Klinische Wochenschrift|August 1, 1982
Protein synthesis in the blood lymphocytes of chronic lymphocytic leukemia and its relationship to prognosisB Emmerich, R Pichlmeier, R Ristione, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 1, 1996
[14C]7-ethoxycoumarin metabolism by precision-cut rat hepatic slicesS E Ball, V E Thiel, C O Tio, et al.Blut|June 20, 1978
[T-cell-antigen positive, E-rosette negative acute lymphoblastic leukaemia (author's transl)]E Thiel, H Rodt, D Netzel, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
Cyclophosphamide, adriamycin and dexamethasone (CAD) is a highly effective therapy for patients with advanced multiple myelomaH Szelényi, E D Kreuser, U Keilholz, et al.Blood|January 1, 1988
Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adultsD Hoelzer, E Thiel, H Löffler, et al.International Journal of Oncology|May 5, 2011
Phase II pilot trial of preoperative high-dose chemotherapy in patients with malignant tumors of the upper gastrointestinal tractW Berdel, T Heldmann, C Germer, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2006
A randomized phase II trial of irinotecan plus carboplatin versus etoposide plus carboplatin treatment in patients with extended disease small-cell lung cancerA Schmittel, L Fischer von Weikersthal, M Sebastian, et al.Onkologie|August 1, 1983
[Recruiting patients and results of a preliminary study on the therapy of acute lymphatic leukemia and acute undifferentiated leukemia in adults]D Hoelzer, E Thiel, H Löffler, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2009
Phase I study of the novel, fully synthetic epothilone sagopilone (ZK-EPO) in patients with solid tumorsP Schmid, P Kiewe, K Possinger, et al.Onkologie|February 1, 1988
[Intensive combined therapy for high-risk ALL patients]D Hoelzer, E Thiel, H Löffler, et al.Pageof 39